These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 29660282)

  • 1. Design, (Radio)Synthesis, and in Vitro and in Vivo Evaluation of Highly Selective and Potent Matrix Metalloproteinase 12 (MMP-12) Inhibitors as Radiotracers for Positron Emission Tomography.
    Butsch V; Börgel F; Galla F; Schwegmann K; Hermann S; Schäfers M; Riemann B; Wünsch B; Wagner S
    J Med Chem; 2018 May; 61(9):4115-4134. PubMed ID: 29660282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiolabeled hydroxamate-based matrix metalloproteinase inhibitors: How chemical modifications affect pharmacokinetics and metabolic stability.
    Hugenberg V; Hermann S; Galla F; Schäfers M; Wünsch B; Kolb HC; Szardenings K; Lebedev A; Walsh JC; Mocharla VP; Gangadharmath UB; Kopka K; Wagner S
    Nucl Med Biol; 2016 Jul; 43(7):424-37. PubMed ID: 27179748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing the Biodistribution of Radiofluorinated Barbiturate Tracers for Matrix Metalloproteinase Imaging by Introduction of Fluorescent Dyes as Pharmacokinetic Modulators.
    Schwegmann K; Hohn M; Hermann S; Schäfers M; Riemann B; Haufe G; Wagner S; Breyholz HJ
    Bioconjug Chem; 2020 Apr; 31(4):1117-1132. PubMed ID: 32181649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new class of highly potent matrix metalloproteinase inhibitors based on triazole-substituted hydroxamates: (radio)synthesis and in vitro and first in vivo evaluation.
    Hugenberg V; Breyholz HJ; Riemann B; Hermann S; Schober O; Schäfers M; Gangadharmath U; Mocharla V; Kolb H; Walsh J; Zhang W; Kopka K; Wagner S
    J Med Chem; 2012 May; 55(10):4714-27. PubMed ID: 22540974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Imaging Probes Based on Matrix Metalloproteinase Inhibitors (MMPIs).
    Rangasamy L; Geronimo BD; Ortín I; Coderch C; Zapico JM; Ramos A; de Pascual-Teresa B
    Molecules; 2019 Aug; 24(16):. PubMed ID: 31426440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Matrix Metalloproteinase 12 Selective Radiotracers for Vascular Molecular Imaging.
    Toczek J; Bordenave T; Gona K; Kim HY; Beau F; Georgiadis D; Correia I; Ye Y; Razavian M; Jung JJ; Lequin O; Dive V; Sadeghi MM; Devel L
    J Med Chem; 2019 Nov; 62(21):9743-9752. PubMed ID: 31603669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofluorinated pyrimidine-2,4,6-triones as molecular probes for noninvasive MMP-targeted imaging.
    Breyholz HJ; Wagner S; Faust A; Riemann B; Höltke C; Hermann S; Schober O; Schäfers M; Kopka K
    ChemMedChem; 2010 May; 5(5):777-89. PubMed ID: 20373323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dual inhibitor of matrix metalloproteinases and a disintegrin and metalloproteinases, [¹⁸F]FB-ML5, as a molecular probe for non-invasive MMP/ADAM-targeted imaging.
    Matusiak N; Castelli R; Tuin AW; Overkleeft HS; Wisastra R; Dekker FJ; Prély LM; Bischoff R; van Waarde A; Dierckx RA; Elsinga PH
    Bioorg Med Chem; 2015 Jan; 23(1):192-202. PubMed ID: 25438884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Potent Proline-Based Metalloproteinase Inhibitors: Design, (Radio)Synthesis, and First in Vivo Evaluation as Radiotracers for Positron Emission Tomography.
    Kalinin DV; Wagner S; Riemann B; Hermann S; Schmidt F; Becker-Pauly C; Rose-John S; Schäfers M; Holl R
    J Med Chem; 2016 Oct; 59(20):9541-9559. PubMed ID: 27696839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and preliminary evaluation in tumor bearing mice of new (18)F-labeled arylsulfone matrix metalloproteinase inhibitors as tracers for positron emission tomography.
    Casalini F; Fugazza L; Esposito G; Cabella C; Brioschi C; Cordaro A; D'Angeli L; Bartoli A; Filannino AM; Gringeri CV; Longo DL; Muzio V; Nuti E; Orlandini E; Figlia G; Quattrini A; Tei L; Digilio G; Rossello A; Maiocchi A
    J Med Chem; 2013 Mar; 56(6):2676-89. PubMed ID: 23458498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical Evaluation of RYM1, a Matrix Metalloproteinase-Targeted Tracer for Imaging Aneurysm.
    Toczek J; Ye Y; Gona K; Kim HY; Han J; Razavian M; Golestani R; Zhang J; Wu TL; Jung JJ; Sadeghi MM
    J Nucl Med; 2017 Aug; 58(8):1318-1323. PubMed ID: 28360209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix Metalloproteinases (MMPs) in Targeted Drug Delivery: Synthesis of a Potent and Highly Selective Inhibitor against Matrix Metalloproteinase- 7.
    Wang LL; Zhang B; Zheng MH; Xie YZ; Wang CJ; Jin JY
    Curr Top Med Chem; 2020; 20(27):2459-2471. PubMed ID: 32703131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and initial evaluation of a high affinity positron emission tomography probe for imaging matrix metalloproteinases 2 and 9.
    Selivanova SV; Stellfeld T; Heinrich TK; Müller A; Krämer SD; Schubiger PA; Schibli R; Ametamey SM; Vos B; Meding J; Bauser M; Hütter J; Dinkelborg LM
    J Med Chem; 2013 Jun; 56(12):4912-20. PubMed ID: 23688254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiolabeled Selective Matrix Metalloproteinase 13 (MMP-13) Inhibitors: (Radio)Syntheses and in Vitro and First in Vivo Evaluation.
    Hugenberg V; Wagner S; Kopka K; Schäfers M; Schuit RC; Windhorst AD; Hermann S
    J Med Chem; 2017 Jan; 60(1):307-321. PubMed ID: 27981835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular imaging of matrix metalloproteinases in vivo using small molecule inhibitors for SPECT and PET.
    Wagner S; Breyholz HJ; Faust A; Höltke C; Levkau B; Schober O; Schäfers M; Kopka K
    Curr Med Chem; 2006; 13(23):2819-38. PubMed ID: 17073631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of structural alterations on the radiopharmacological profile of
    Tietz O; Marshall A; Bergman C; Wuest M; Wuest F
    Nucl Med Biol; 2018; 62-63():9-17. PubMed ID: 29800798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of matrix metalloproteinase-targeted probes for lung inflammation detection with positron emission tomography.
    Kondo N; Temma T; Aita K; Shimochi S; Koshino K; Senda M; Iida H
    Sci Rep; 2018 Jan; 8(1):1347. PubMed ID: 29358724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New in Vivo Compatible Matrix Metalloproteinase (MMP)-2 and MMP-9 Inhibitors.
    Beutel B; Song J; Konken CP; Korpos E; Schinor B; Gerwien H; Vidyadharan R; Burmeister M; Li L; Haufe G; Sorokin L
    Bioconjug Chem; 2018 Nov; 29(11):3715-3725. PubMed ID: 30277751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inverse 1,2,3-triazole-1-yl-ethyl substituted hydroxamates as highly potent matrix metalloproteinase inhibitors: (radio)synthesis, in vitro and first in vivo evaluation.
    Hugenberg V; Riemann B; Hermann S; Schober O; Schäfers M; Szardenings K; Lebedev A; Gangadharmath U; Kolb H; Walsh J; Zhang W; Kopka K; Wagner S
    J Med Chem; 2013 Sep; 56(17):6858-70. PubMed ID: 23899323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new generation of radiofluorinated pyrimidine-2,4,6-triones as MMP-targeted radiotracers for positron emission tomography.
    Schrigten D; Breyholz HJ; Wagner S; Hermann S; Schober O; Schäfers M; Haufe G; Kopka K
    J Med Chem; 2012 Jan; 55(1):223-32. PubMed ID: 22118188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.